Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2021 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Colchicine and risk of hospitalization due to COVID-19: A population-based study.
Sáenz-Aldea M, Salgado-Barreira Á, Taracido Trunk M, Piñeiro-Lamas M, Herdeiro MT, Portela-Romero M, Saez M, Figueiras A. Sáenz-Aldea M, et al. Among authors: taracido trunk m. J Med Virol. 2023 Feb;95(2):e28496. doi: 10.1002/jmv.28496. J Med Virol. 2023. PMID: 36639903 Free PMC article.
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group. García-Álvarez RM, et al. Inflammopharmacology. 2024 Apr 15. doi: 10.1007/s10787-024-01475-2. Online ahead of print. Inflammopharmacology. 2024. PMID: 38619761
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study.
Rodríguez-Fernández A, Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, García-Álvarez RM, Herdeiro TM, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á; COVIDRUG Group. Rodríguez-Fernández A, et al. Inflammopharmacology. 2024 May 2. doi: 10.1007/s10787-024-01474-3. Online ahead of print. Inflammopharmacology. 2024. PMID: 38698179